These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 1692474

  • 1. Markers for proliferation and keratinization in the margin of the active psoriatic lesion.
    de Mare S, de Jong E, Van Erp PE, Van de Kerkhof PC.
    Br J Dermatol; 1990 Apr; 122(4):469-75. PubMed ID: 1692474
    [Abstract] [Full Text] [Related]

  • 2. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE, van Duijnhoven MW, Pasch MC, van Erp PE, van de Kerkhof PC.
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [Abstract] [Full Text] [Related]

  • 3. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
    Gerritsen MJ, Elbers ME, de Jong EM, van de Kerkhof PC.
    J Dermatol Sci; 1997 Mar; 14(3):179-88. PubMed ID: 9138475
    [Abstract] [Full Text] [Related]

  • 4. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
    Mommers JM, van Rossum MM, van Erp PE, van De Kerkhof PC.
    Dermatology; 2000 Mar; 201(1):15-20. PubMed ID: 10971053
    [Abstract] [Full Text] [Related]

  • 5. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.
    de Mare S, Van Erp PE, van de Kerkhof PC.
    J Invest Dermatol; 1989 Jan; 92(1):130-1. PubMed ID: 2462594
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE, Rijzewijk JJ, Boezeman JB, Leenders J, de Mare S, Schalkwijk J, van de Kerkhof PC, Ramaekers FC, Bauer FW.
    Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
    [Abstract] [Full Text] [Related]

  • 7. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
    Mommers JM, Goossen JW, van De Kerkhof PC, van Erp PE.
    Cytometry; 2000 Feb 15; 42(1):43-9. PubMed ID: 10679742
    [Abstract] [Full Text] [Related]

  • 8. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
    Castelijns FA, Gerritsen MJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC.
    J Am Acad Dermatol; 1999 Jun 15; 40(6 Pt 1):901-9. PubMed ID: 10365920
    [Abstract] [Full Text] [Related]

  • 9. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
    Vissers WH, Arndtz CH, Muys L, Van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2004 May 15; 150(5):852-9. PubMed ID: 15149496
    [Abstract] [Full Text] [Related]

  • 10. Quantification of epidermal cell populations in the centre and margin of stable psoriatic plaques.
    Mommers JM, van Rossum MM, van Hooijdonk CA, van Erp PE, van de Kerkhof PC.
    Arch Dermatol Res; 1999 May 15; 291(2-3):88-92. PubMed ID: 10195395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
    Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN.
    Br J Dermatol; 1995 Oct 15; 133(4):501-11. PubMed ID: 7577575
    [Abstract] [Full Text] [Related]

  • 13. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
    Bhawan J, Bansal C, Whren K, Schwertschlag U, IL-11 Psoriasis Study Group.
    J Cutan Pathol; 2004 Aug 15; 31(7):471-6. PubMed ID: 15239676
    [Abstract] [Full Text] [Related]

  • 14. Response of the clinically uninvolved skin of psoriatic patients to tape stripping during acitretin treatment.
    Gerritsen MJ, van Pelt JP, van de Kerkhof PC.
    Acta Derm Venereol; 1996 Jan 15; 76(1):6-9. PubMed ID: 8721480
    [Abstract] [Full Text] [Related]

  • 15. Epidermal proliferation and accumulation of polymorphonuclear leukocytes in the psoriatic lesion.
    Beurskens T, Chang A, van Erp PE, van de Kerkhof PC.
    Dermatologica; 1989 Jan 15; 178(2):67-72. PubMed ID: 2924984
    [Abstract] [Full Text] [Related]

  • 16. Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
    van Lingen RG, Poll MK, Seyger MM, de Jong EM, van de Kerkhof PC, van Erp PE.
    Arch Dermatol Res; 2008 Nov 15; 300(10):561-7. PubMed ID: 18496701
    [Abstract] [Full Text] [Related]

  • 17. Delayed onset of epidermal differentiation in psoriasis.
    Bernerd F, Magnaldo T, Darmon M.
    J Invest Dermatol; 1992 Jun 15; 98(6):902-10. PubMed ID: 1375620
    [Abstract] [Full Text] [Related]

  • 18. Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.
    de Zwart AJ, de Jong EM, van de Kerkhof PC.
    Skin Pharmacol; 1992 Jun 15; 5(1):34-40. PubMed ID: 1374264
    [Abstract] [Full Text] [Related]

  • 19. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis.
    Ishida-Yamamoto A, Senshu T, Takahashi H, Akiyama K, Nomura K, Iizuka H.
    J Invest Dermatol; 2000 Apr 15; 114(4):701-5. PubMed ID: 10733676
    [Abstract] [Full Text] [Related]

  • 20. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
    Kuijpers AL, Bergers M, Siegenthaler G, Zeeuwen PL, van de Kerkhof PC, Schalkwijk J.
    Acta Derm Venereol; 1997 Jan 15; 77(1):14-9. PubMed ID: 9059669
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.